OpenURL Connection Search

Select item for more details and to access through your institution.

Treatment of Marburg Variant Multiple Sclerosis with Mitoxantrone.
Published in:
Journal of Neuroimaging, 2004, v. 14, n. 1, p. 58, doi. 10.1177/1051228403259393
By:
- Douglas R. Jeffery;
- David S. Lefkowitz;
- Jeffrey P. Crittenden
Publication type:
Article
A pilot trial of combination therapy with mitoxantrone and interferon beta-1b using monthly gadolinium-enhanced magnetic resonance imaging.
Published in:
Multiple Sclerosis (13524585), 2005, v. 11, n. 3, p. 296, doi. 10.1191/1352458505ms1154oa
By:
- Jeffery, Douglas R.;
- Chepuri, Neraj;
- Durden, David;
- Burdette, Jonathon
Publication type:
Article
The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic Protease.
Published in:
Angewandte Chemie, 2011, v. 123, n. 26, p. 6011, doi. 10.1002/ange.201101740
By:
- Schmitt, Esther K.;
- Riwanto, Meliana;
- Sambandamurthy, Vasan;
- Roggo, Silvio;
- Miault, Charlotte;
- Zwingelstein, Christian;
- Krastel, Philipp;
- Noble, Christian;
- Beer, David;
- Rao, Srinivasa P. S.;
- Au, Melvin;
- Niyomrattanakit, Pornwaratt;
- Lim, Viviam;
- Zheng, Jun;
- Jeffery, Douglas;
- Pethe, Kevin;
- Camacho, Luis R.
Publication type:
Article
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.
Published in:
Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 565, doi. 10.1177/1352458518763089
By:
- Buck, Dorothea;
- Andlauer, Till F. M.;
- Igl, Wilmar;
- Wicklein, Eva-Maria;
- Mühlau, Mark;
- Weber, Frank;
- Köchert, Karl;
- Pohl, Christoph;
- Arnason, Barry;
- Comi, Giancarlo;
- Cook, Stuart;
- Filippi, Massimo;
- Hartung, Hans-Peter;
- Jeffery, Douglas;
- Kappos, Ludwig;
- Barkhof, Frederik;
- Edan, Gilles;
- Freedman, Mark S.;
- Montalbán, Xavier;
- Müller-Myhsok, Bertram
Publication type:
Article
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2017, v. 23, n. 1, p. 94, doi. 10.1177/1352458516638941
By:
- Cadavid, Diego;
- Kinch, Deborah;
- Lee, Sophia;
- Shang, Shulian;
- Mikol, Daniel;
- Sellebjerg, Finn;
- Cohen, Jeffrey A.;
- Freedman, Mark S.;
- Goldman, Myla D.;
- Hartung, Hans-Peter;
- Havrdova, Eva;
- Jeffery, Douglas;
- Kapoor, Raj;
- Miller, Aaron
Publication type:
Article
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial.
Published in:
Multiple Sclerosis Journal, 2012, v. 18, n. 2, p. 181, doi. 10.1177/1352458511418629
By:
- Goodin, Douglas S;
- Hartung, Hans-Peter;
- O’Connor, Paul;
- Filippi, Massimo;
- Arnason, Barry;
- Comi, Giancarlo;
- Cook, Stuart;
- Jeffery, Douglas;
- Kappos, Ludwig;
- Bogumil, Timon;
- Knappertz, Volker;
- Sandbrink, Rupert;
- Beckmann, Karola;
- White, Rick;
- Petkau, John;
- Pohl, Christoph
Publication type:
Article
Combining CAT with cognitive diagnosis: A weighted item selection approach.
Published in:
Behavior Research Methods, 2012, v. 44, n. 1, p. 95, doi. 10.3758/s13428-011-0143-3
By:
- Wang, Chun;
- Chang, Hua-Hua;
- Douglas, Jeffery
Publication type:
Article
Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study.
Published in:
BMC Neurology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2377-13-80
By:
- Rivera, Victor M.;
- Jeffery, Douglas R.;
- Weinstock-Guttman, Bianca;
- Bock, Daena;
- Dangond, Fernando
Publication type:
Article
Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study.
Published in:
2013
By:
- Rivera, Victor M;
- Jeffery, Douglas R;
- Weinstock-Guttman, Bianca;
- Bock, Daena;
- Dangond, Fernando
Publication type:
journal article
Factors that influence adherence with disease-modifying therapy in MS.
Published in:
Journal of Neurology, 2009, v. 256, n. 4, p. 568, doi. 10.1007/s00415-009-0096-y
By:
- Treadaway, Katherine;
- Cutter, Gary;
- Salter, Amber;
- Lynch, Sharon;
- Simsarian, James;
- Corboy, John;
- Jeffery, Douglas;
- Cohen, Bruce;
- Mankowski, Ken;
- Guarnaccia, Joseph;
- Schaeffer, Lawrence;
- Kanter, Roy;
- Brandes, David;
- Kaufman, Charles;
- Duncan, David;
- Marder, Ellen;
- Allen, Arthur;
- Harney, John;
- Cooper, Joanna;
- Woo, Douglas
Publication type:
Article
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Published in:
JAMA Neurology, 2015, v. 72, n. 12, p. 1458, doi. 10.1001/jamaneurol.2015.2742
By:
- Fitzgerald, Kathryn C.;
- Munger, Kassandra L.;
- Köchert, Karl;
- Arnason, Barry G. W.;
- Comi, Giancarlo;
- Cook, Stuart;
- Goodin, Douglas S.;
- Filippi, Massimo;
- Hartung, Hans-Peter;
- Jeffery, Douglas R.;
- O'Connor, Paul;
- Suarez, Gustavo;
- Sandbrink, Rupert;
- Kappos, Ludwig;
- Pohl, Christoph;
- Ascherio, Alberto
Publication type:
Article
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis.
Published in:
JAMA Neurology, 2013, v. 70, n. 8, p. 1017, doi. 10.1001/jamaneurol.2013.192
By:
- Hartung, Hans-Peter;
- Steinman, Lawrence;
- Goodin, Douglas S.;
- Comi, Giancarlo;
- Cook, Stuart;
- Filippi, Massimo;
- O'Connor, Paul;
- Jeffery, Douglas R.;
- Kappos, Ludwig;
- Axtell, Robert;
- Knappertz, Volker;
- Bogumil, Timon;
- Schwenke, Susanne;
- Croze, Ed;
- Sandbrink, Rupert;
- Pohl, Christopher
Publication type:
Article
US Food and Drug Administration Perspectives on Clinical Mass Spectrometry.
Published in:
Clinical Chemistry, 2016, v. 62, n. 1, p. 41, doi. 10.1373/clinchem.2015.244731
By:
- Lathrop, Julia Tait;
- Jeffery, Douglas A.;
- Shea, Yvonne R.;
- Scholl, Peter F.;
- Chan, Maria M.
Publication type:
Article
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Published in:
Journal of Neurology, 2016, v. 263, n. 7, p. 1418, doi. 10.1007/s00415-016-8146-8
By:
- Schippling, Sven;
- O'Connor, Paul;
- Knappertz, Volker;
- Pohl, Christoph;
- Bogumil, Timon;
- Suarez, Gustavo;
- Cook, Stuart;
- Filippi, Massimo;
- Hartung, Hans-Peter;
- Comi, Giancarlo;
- Jeffery, Douglas;
- Kappos, Ludwig;
- Goodin, Douglas;
- Arnason, Barry
Publication type:
Article
The relationship between the rate of brain volume loss during first 24 months and disability progression over 24 and 48 months in relapsing MS.
Published in:
Journal of Neurology, 2016, v. 263, n. 2, p. 299, doi. 10.1007/s00415-015-7959-1
By:
- Jeffery, Douglas;
- Cantogno, Elisabetta;
- Ritter, Shannon;
- Meier, Daniela;
- Radue, Ernst-Wilhelm;
- Camu, William
Publication type:
Article
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Published in:
Journal of Neurology, 2015, v. 262, n. 11, p. 2466, doi. 10.1007/s00415-015-7862-9
By:
- Hartung, Hans-Peter;
- Kappos, Ludwig;
- Goodin, Douglas;
- O'Connor, Paul;
- Filippi, Massimo;
- Arnason, Barry;
- Comi, Giancarlo;
- Cook, Stuart;
- Jeffery, Douglas;
- Petkau, John;
- White, Richard;
- Bogumil, Timon;
- Beckmann, Karola;
- Stemper, Brigitte;
- Suarez, Gustavo;
- Sandbrink, Rupert;
- Pohl, Christoph
Publication type:
Article
Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE.
Published in:
Journal of Neurology, 2015, v. 262, n. 2, p. 326, doi. 10.1007/s00415-014-7558-6
By:
- Kaufman, Michael;
- Cree, Bruce;
- Sèze, Jerome;
- Fox, Robert;
- Gold, Ralf;
- Hartung, Hans-Peter;
- Jeffery, Douglas;
- Kappos, Ludwig;
- Montalbán, Xavier;
- Weinstock-Guttman, Bianca;
- Ticho, Barry;
- Duda, Petra;
- Pace, Amy;
- Campagnolo, Denise
Publication type:
Article
Efficacy and safety of interferon beta-1b sc in older RRMS patients-a posthoc analysis of the BEYOND study.
Published in:
Journal of Neurology, 2013, v. 260, n. 7, p. 1838, doi. 10.1007/s00415-013-6888-0
By:
- Lampl, Christian;
- Nagl, Stefan;
- Arnason, Barry;
- Comi, Giancarlo;
- O′Connor, Paul;
- Cook, Stuart;
- Jeffery, Douglas;
- Kappos, Ludwig;
- Filippi, Massimo;
- Beckmann, Karola;
- Bogumil, Timon;
- Pohl, Christoph;
- Sandbrink, Rupert;
- Hartung, Hans
Publication type:
Article
Best practice recommendations for the selection and management of patients with multiple sclerosis receiving natalizumab therapy.
Published in:
Multiple Sclerosis (13524585), 2009, v. 15, n. S4, p. S26, doi. 10.1177/1352458509347131
By:
- Coyle, Patricia K.;
- Foley, John F.;
- Fox, Edward J.;
- Jeffery, Douglas R.;
- Munschauer III, Frederick E.;
- Tornatore, Carlo
Publication type:
Article
Clinical efficacy and benefit of natalizumab.
Published in:
Multiple Sclerosis (13524585), 2009, v. 15, n. S4, p. S7, doi. 10.1177/1352458509347129
By:
- Coyle, Patricia K.;
- Jeffery, Douglas R.
Publication type:
Article
Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study.
Published in:
Therapeutic Advances in Neurological Disorders, 2011, v. 4, n. 1, p. 3, doi. 10.1177/1756285610391693
By:
- Uitdehaag, Bernard;
- Constantinescu, Cris;
- Cornelisse, Peter;
- Jeffery, Douglas;
- Kappos, Ludwig;
- Li, David;
- Sandberg-Wollheim, Magnhild;
- Traboulsee, Anthony;
- Verdun, Elisabetta;
- Rivera, Victor
Publication type:
Article
Chemotherapeutics in the treatment of multiple sclerosis.
Published in:
Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 5, p. 277, doi. 10.1177/1756285610379885
By:
- Kieseier, Bernd C.;
- Jeffery, Douglas R.
Publication type:
Article
Purification and Kinetic Mechanism of Human Brain Soluble Catechol- O-Methyltransferase.
Published in:
Journal of Neurochemistry, 1985, v. 44, n. 3, p. 881, doi. 10.1111/j.1471-4159.1985.tb12898.x
By:
- Jeffery, Douglas R.;
- Roth, Jerome A.
Publication type:
Article
Characterization of Membrane-Bound and Soluble Catechol- O-Methyltransferase from Human Frontal Cortex.
Published in:
Journal of Neurochemistry, 1984, v. 42, n. 3, p. 826, doi. 10.1111/j.1471-4159.1984.tb02755.x
By:
- Jeffery, Douglas R.;
- Roth, Jerome A.
Publication type:
Article
Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies.
Published in:
2012
By:
- Hartung, Hans-Peter;
- Kieseier, Bernd;
- Goodin, Douglas S;
- Arnason, Barry Gw;
- Comi, Giancarlo;
- Cook, Stuart;
- Filippi, Massimo;
- Jeffery, Douglas R;
- Kappos, Ludwig;
- Bogumil, Timon;
- Stemper, Brigitte;
- Sandbrink, Rupert;
- Nakada, Yukiko;
- Nakajima, Haruhiko;
- Schwenke, Susanne;
- Lehr, Stephan;
- Heubach, Jürgen;
- Pohl, Christoph;
- Reischl, Joachim
Publication type:
journal article
Discovery of Selective Irreversible Inhibitors for Bruton's Tyrosine Kinase.
Published in:
ChemMedChem, 2007, v. 2, n. 1, p. 58, doi. 10.1002/cmdc.200600221
By:
- Pan, Zhengying;
- Scheerens, Heleen;
- Li, Shyr-Jiann;
- Schultz, Brian E.;
- Sprengeler, Paul A.;
- Burrill, L. Chuck;
- Mendonca, Rohan V.;
- Sweeney, Michael D.;
- Scott, Keana C. K.;
- Grothaus, Paul G.;
- Jeffery, Douglas A.;
- Spoerke, Jill M.;
- Honigberg, Lee A.;
- Young, Peter R.;
- Dalrymple, Stacie A.;
- Palmer, James T.
Publication type:
Article
Devic's neuromyelitis optica: A clinicopathological study of 8 patients.
Published in:
Annals of Neurology, 1993, v. 34, n. 2, p. 162, doi. 10.1002/ana.410340211
By:
- Mandler, Raül N.;
- Davis, Larry E.;
- Jeffery, Douglas R.;
- Kornfeld, Mario
Publication type:
Article
The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic Protease.
Published in:
Angewandte Chemie International Edition, 2011, v. 50, n. 26, p. 5889, doi. 10.1002/anie.201101740
By:
- Schmitt, Esther K.;
- Riwanto, Meliana;
- Sambandamurthy, Vasan;
- Roggo, Silvio;
- Miault, Charlotte;
- Zwingelstein, Christian;
- Krastel, Philipp;
- Noble, Christian;
- Beer, David;
- Rao, Srinivasa P. S.;
- Au, Melvin;
- Niyomrattanakit, Pornwaratt;
- Lim, Viviam;
- Zheng, Jun;
- Jeffery, Douglas;
- Pethe, Kevin;
- Camacho, Luis R.
Publication type:
Article

Found: 28